TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational ...

TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral ...
Brampton Guardian

October Ontario and Canada government benefits breakdown: Key dates for CPP, child benefit, OTB, OAS and more

The GST/HST credit, Advanced Canada Workers Benefit, Ontario Trillium Benefit, Canada Child Benefit, Canada Pension Plan and ...